TT-06 Study, sponsored by ALK-Abello

A new visit of the site's initiation: sublingual immunotherapy of tree pollen allergy, sponsored by the pharmaceutical company ALK-Abello, Denmark. We invite patients from 5 to 17 years old!

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen